1. Home
  2. STOK vs STRA Comparison

STOK vs STRA Comparison

Compare STOK & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$36.53

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

STRA

Strategic Education Inc.

HOLD

Current Price

$83.46

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
STOK
STRA
Founded
2014
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
STOK
STRA
Price
$36.53
$83.46
Analyst Decision
Strong Buy
Buy
Analyst Count
10
3
Target Price
$39.20
$92.67
AVG Volume (30 Days)
687.2K
229.3K
Earning Date
05-12-2026
04-23-2026
Dividend Yield
N/A
2.88%
EPS Growth
92.73
15.85
EPS
N/A
5.41
Revenue
$184,420,000.00
$997,137,000.00
Revenue This Year
N/A
$3.93
Revenue Next Year
$77.49
$4.93
P/E Ratio
N/A
$15.38
Revenue Growth
404.50
57.23
52 Week Low
$8.30
$72.17
52 Week High
$40.22
$92.98

Technical Indicators

Market Signals
Indicator
STOK
STRA
Relative Strength Index (RSI) 58.53 54.88
Support Level $30.34 $79.21
Resistance Level $39.00 $85.58
Average True Range (ATR) 1.77 2.10
MACD 0.34 -0.04
Stochastic Oscillator 84.76 64.71

Price Performance

Historical Comparison
STOK
STRA

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: